The main objective is to determine the clinical utility of non-invasive methods for measuring fibrosis in the initial assessment and follow-up of chronic hepatitis B in untreated adults.
In the absence of sufficient demonstration of this clinical utility, the diagnostic performances of these non-invasive methods will be defined, in comparison with liver biopsy
See also
HAS opinions and decisions
19/06/2014
Practice guidelines
07/05/2009
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
3pWbVs7XaAxnzQTX